Adriana Perilla Glen

Mother. Senior Program Manager at @DanaFarber Cancer Institute. Babson MBA. Avid lifelong learner. Traveler. Baker. Tweets are my own.

[Adriana Perilla Glen @aperillaglen1]

President Laurie Glimcher, MD at the Helen Gurley Brown Presidential Summit on Women and Science @DanaFarber

[Mark Bustoros @MarkBustoros]

Great news for those with precursor conditions like #MGUS #CHIP #SMM #MBL #CCUS. The Center for prevention of Progression of Blood Cancers @DanaFarber will open a new clinical center for following up these patients under the leadership of @IreneGhobrial and @DavidSteensma. #mmsm

[Stand Up To Cancer @SU2C]

The next breakthrough is within our reach. Retweet if you agree. #StandUpToCancer

[Adriana Perilla Glen @aperillaglen1]

The Dana-Farber communications team is filming informational videos for our PCROWD study. Today, Tarek Mouhieddine, a research postdoctoral fellow at the Ghobrial Lab, talks about his research and the use of PCROWD samples for scientific discovery. @IreneGhobrial @DanaFarber

[Stand Up To Cancer @SU2C]

Tune in LIVE on our Facebook today at 6:30pm ET/ 3:30pm PT to learn about the new #SU2C Multiple Myeloma Dream Team and @StBaldricks – SU2C Pediatric Cancer Dream Team, along with our groundbreaking partnership with the @lustgartenFDN.

https://t.co/UHi2ocm7bC @AACR

[Dana-Farber @DanaFarber]

Happy #NationalDoctorsDay to all of our oncologists at Dana-Farber & beyond! Thank you for your tireless service to patients and families everywhere. https://t.co/iYiQmQCWMb

[Barack Obama @BarackObama]

Michelle and I are so inspired by all the young people who made today’s marches happen. Keep at it. You’re leading us forward. Nothing can stand in the way of millions of voices calling for change.

[Mark Bustoros @MarkBustoros]

A minireview with @IreneGhobrial on MGUS and the substantial contribution of Dr. Robert Kyle in defining this condition. #DFCI #mmsm
When Does Monoclonal Gammopathy Acquire Significance? https://t.co/18fyjUotZD

[Adriana Perilla Glen @aperillaglen1]

Dr. Mohamed Azzazi starts his presentation discussing the high cost for patients with multiple myeloma in Egypt - over 40% out of pocket. #HOPE2018 @IreneGhobrial

[Adriana Perilla Glen @aperillaglen1]

Dr. Joseph Mikhael talks about the future of myeloma and all the drugs available to myeloma patients that will significantly change how it is treated for in the future. @jmikhaelmd @IreneGhobrial

[Adriana Perilla Glen @aperillaglen1]

Dr. Mohamed Khalaf, from the Oncology-Hematology Hospital at the Maadi Armed Forces Medical Compound in Egypt presenting on Egyptian standard of care for patients with newly diagnosed myeloma. @IreneGhobrial @jmikhaelmd

[Joseph Mikhael @jmikhaelmd]

Bringing HOPE to Egypt to help cancer patients across the nation. @IreneGhobrial @aperillaglen1

[Adriana Perilla Glen @aperillaglen1]

Dr. Thorya Abd Al-Hameed from the National Cancer Institute in Egypt presents on CLL Egyptian standard of care at #HOPE2018

[Adriana Perilla Glen @aperillaglen1]

Dr. DeAngelo talks about mutations that present a poor prognosis in AML and Key Points from de novo AML Genome Atlas at the #HOPE2018 educational meeting in Cairo Egypt.

[Adriana Perilla Glen @aperillaglen1]

Dr. Daniel DeAngelo talking about US standard of care for MDS and MPN at the Hematology-Oncology Practice and Education meeting #HOPE2018 in Cairo, Egypt.

[Adriana Perilla Glen @aperillaglen1]

Excited to be in Cairo, Egypt for the 1st international #HOPE2018 educational meeting in collaboration with our Egyptian counterparts. Dr. Mikhael, guest speaker @jmikhaelmd starting out the meeting. @IreneGhobrial

[Adriana Perilla Glen @aperillaglen1]

Very proud of the work we are doing using PCROWD samples @IreneGhobrial lab @DanaFarber. Learn more here: https://t.co/RJsIP8WUim https://t.co/syVEMBfRd0

[Adriana Perilla Glen @aperillaglen1]

72% overall response rate with 56% CR + PR with BLU-285 treatment in patients with advanced systemic mastocytosis https://t.co/4XDZt3XVqp. Plenary session #ASH17. Important work by Dr. Dan DeAngelo @DanaFarber

[. @IreneGhobrial]

Ben Ebert presenting about chip #ash17

[Dana-Farber @DanaFarber]

Today’s plenary at 2pm includes Dana-Farber’s Dr. Dan DeAngelo on Blu-285 for advanced systemic #mastocytosis. Learn more: https://t.co/NJuQu5gyzS #ASH17